Key aspects of the Complainant’s contentions are summarized below.<\/p>\n
Complainant’s Background<\/strong><\/p>\n The Complainant, Boehringer Ingelheim Animal Health, is a global leader in the animal health industry and forms part of the family-owned company Boehringer Ingelheim, founded in 1885. With more than 9,500 employees serving over 150 markets worldwide, Complainant is one of the largest providers of vaccines, parasiticides and therapeutics, complemented by diagnostics and monitoring platforms. <\/span><\/p>\n The Complainant’s product FRONTLINE is a well-known brand used for the treatment and prevention of fleas, ticks, and chewing lice in dogs and cats. It also helps break the flea life cycle by stopping the development of immature stages and supports the control of sarcoptic mange in dogs.<\/span><\/p>\n Registration of the disputed domain name<\/strong><\/p>\n According to the Complainant and the corresponding WHOIS records, the disputed domain name <frontlineplus-spot-on.com> was registered on November 10, 2025. Based on the screenshot evidence submitted with the complaint, the disputed domain name redirected to an authentication page requesting users to enter an email address and submit it.<\/span><\/p>",
"other_legal_proceedings": " The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
"no_response_filed": " COMPLAINANT:<\/strong><\/p>\n The Complainant’s contentions may be summarized as follows:<\/p>\n The disputed domain name is confusingly similar to the Complainant’s trademark FRONTLINE, as the mark is identically contained. The addition of terms like “PLUS,” “SPOT,” and “ON” reinforces the connection to the Complainant's products and increases the likelihood of consumer confusion because it refers to a specific product commercialized by the Complainant<\/span>.<\/p>\n The Respondent has no rights or legitimate interests in the disputed domain name. The Complainant has made a prima facie<\/em> case, noting that the Respondent is not commonly known by the disputed domain name, is not affiliated with the Complainant, and has no authorization to use the FRONTLINE mark. The Complainant claims the disputed domain name resolves to an authentication page, which is not a bona fide<\/em> offering of services and misleads consumers into believing they are accessing a Complainant-related site.<\/p>\n The disputed domain name was registered and is being used in bad faith. Given that the Complainant's FRONTLINE trademarks are well-known, the Respondent was clearly aware of them upon registration. By using the disputed domain name to direct users to an authentication page, the Respondent intentionally seeks to exploit the Complainant’s reputation and create a likelihood of confusion as to the source or affiliation of the website for commercial gain, potentially to collect personal information.<\/span><\/p>\n The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n RESPONDENT:<\/strong><\/p>\n No administratively compliant Response has been filed.<\/p>",
"rights": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
"no_rights_or_legitimate_interests": " The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
"bad_faith": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
"procedural_factors": " The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
"decision": "Accepted",
"panelists": [
"Claire Kowarsky (Presiding Panelist)"
],
"date_of_panel_decision": "2025-12-12 00:00:00",
"informal_english_translation": " The Complainant relies on its registered trademark:<\/p>\n <\/p>\n Mark<\/p>\n<\/td>\n Territory<\/p>\n<\/td>\n Registration No.<\/p>\n<\/td>\n Registration Date<\/p>\n<\/td>\n Classes<\/p>\n<\/td>\n<\/tr>\n FRONTLINE<\/p>\n <\/p>\n <\/p>\n<\/td>\n IR WIPO<\/p>\n Designations: AT - BG - BX - CH - CN - CZ - DE - DZ - ES - HR - HU - IT - LV - MA - ME - PL - PT - RO - RS - RU - SI - SK - UA<\/p>\n<\/td>\n 621912<\/p>\n<\/td>\n June 09, 1994<\/p>\n<\/td>\n 05<\/p>\n<\/td>\n<\/tr>\n FRONTLINE<\/p>\n<\/td>\n IR WIPO<\/p>\n Designations: DK - EE - EM - FI - GB - GR - IE - IL - KR - LT - NO - PH - SE - SG – TN - AT - BG - BX - CH - CZ - DE - DZ - EG - HR - HU - KE - LV - MA - ME - PL - PT - RO - RS - SI - SK - UA - VN<\/p>\n<\/td>\n 1245236<\/p>\n<\/td>\n January 30, 2015<\/p>\n<\/td>\n 03, 05<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n <\/p>\n Further, the Complainant operates its business using its domain name <frontline.com>, registered and used since January 28, 1999.<\/span><\/p>",
"decision_domains": {
"frontlineplus-spot-on.com": "TRANSFERRED"
}
}\n\n
\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n